Newsletter | October 24, 2025

10.24.25 -- Reducing Legal Spend Without Compromising Quality

FEATURED ARTICLE

Strategic Approaches To Reducing Legal Spend Without Compromising Quality

Firm consolidation, thoughtful staffing, disciplined scope control, and performance accountability can save life sciences companies real money on legal expenses, writes Snell & Wilmer's April Wurster.

INDUSTRY INSIGHTS

Advancing The Implementation Of ICH E17

Explore the ICH E17 guidelines that provide a harmonized framework for designing and conducting multiregional clinical trials (MRCTs) to meet the regulatory expectations of multiple regions.

Patient Trust And Engagement In The Age Of Decentralized Trials

Building patient trust through dedicated support roles is the key to moving beyond awareness and achieving reliable enrollment. Discover how to prioritize relationship-building in your trials.

Enhancing Cell Growth With Cytokines

With 4,800 immune cell therapy products in development, cytokines are crucial for cultivating diverse immune cells. Fine-tuning cytokines can enhance cell proliferation and advance immune cell therapy efficacy.

Patient Empowerment Through The European Health Data Space (EHDS)

A new regulation in the EU will give patients more control over their health data. Discover the opportunities and challenges this shift presents for the future of patient-centric healthcare.

Enhancing Patient Adherence Through Autoinjector Access

As autoinjectors evolve to accommodate a diverse array of chronic diseases, consider the impact of partnering with experienced device manufacturers and fill/finish providers.

CONTRIBUTE TO LIFE SCIENCE LEADER

Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable?  Read these guidelines first before submitting your idea or your article to our editorial director.